Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 2151 3683 3686 3715
This examiner grants 46% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19357681 | ARCHITECTURE FOR INTEROPERABLE UROLOGY OPERATING ROOM | Non-Final OA | Boston Scientific Scimed, Inc. |
| 19068356 | SYSTEMS AND METHODS FOR COORDINATION OF MEDICATION ADJUSTMENT AND NEUROMODULATION THERAPY | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 18889904 | SYSTEMS AND METHODS FOR DESIGNING AND CONDUCTING CLINICAL TRIALS AND BIOMARKER VALIDATION STUDIES | Non-Final OA | Flagship Pioneering Innovations VII, LLC |
| 19026257 | INFORMATION INTERACTION METHOD, PLATFORM, DEVICE, AND NON-TRANSITORY COMPUTER STORAGE MEDIUM | Final Rejection | BOE Technology Group Co., Ltd. |
| 18106896 | Establishing Network Pairing | Final Rejection | Stryker Corporation |
| 18833082 | GUIDANCE ASSISTANCE APPARATUS, GUIDANCE ASSISTANCE METHOD, AND COMPUTER-READABLE RECORDING MEDIUM | Final Rejection | NEC Corporation |
| 18713777 | STRESS ESTIMATION METHOD | Final Rejection | NEC Corporation |
| 19239078 | AI-BASED CALCULATION OF A CASE COMPLEXITY INDEX | Non-Final OA | Siemens Healthineers AG |
| 18713758 | SYSTEMS AND METHODS FOR IDENTIFYING SUBJECTS FOR CLINICAL TRIALS | Final Rejection | Eli Lilly and Company |
| 19228075 | SYSTEM AND METHOD FOR EXTRACTING, USING AN ARTIFICIAL INTELLIGENCE MODEL, CRITERIA FOR DETERMINING A DIAGNOSIS BY A RULE-BASED ECG ANALYSIS MODEL | Non-Final OA | GE Precision Healthcare LLC |
| 18954228 | CONFLICTING DATA STREAMS IN MULTI-SYSTEM INTERACTION | Non-Final OA | Cilag GmbH International |
| 19250451 | SYSTEMS AND METHODS FOR PREDICTIVE ANOMALY DETECTION IN PHARMACEUTICAL PROCESSING DATA | Non-Final OA | Express Scripts Strategic Development, Inc. |
| 18501189 | SYSTEMS AND METHODS FOR EFFICIENT PROCESSING OF DATA ASSOCIATED WITH SYSTEM RESOURCES | Non-Final OA | Optum Services (Ireland) Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy